| 1 |
Lin L, Yan L, Liu Y, et al. The burden and trends of primary liver cancer caused by specific etiologies from 1990 to 2017 at the global, regional, national, age, and sex level results from the global burden of disease study 2017[J]. Liver Cancer, 2020, 9(5): 563-582.
|
| 2 |
Hong SK, Jin XL, Suh S, et al. Different risk factors for early and late recurrence after curative resection of hepatocellular carcinoma[J]. World J Surg, 2022, 46(1): 197-206.
|
| 3 |
Li X, Gu B, Wang B, et al. Intrahepatic metastases may be specific to hepatocellular carcinoma due to the coagulation and fibrinolytic systems (review)[J]. Oncol Rep, 2020, 44(6): 2345-2352.
|
| 4 |
He C, Zhou Z, Xiao Z, et al. Treatment strategy for huge hepatocellular carcinoma with intrahepatic metastasis and macrovascular invasion: a case report and literature review[J]. J Cancer Res Ther, 2018, 14: 1233-1236.
|
| 5 |
Kudo M, Izumi N, Kokudo N, et al. Report of the 22nd nationwide follow-up survey of primary liver cancer in japan (2012-2013)[J]. Hepatol Res, 2022, 52(1): 5-66.
|
| 6 |
Sun J, Guo R, Bi X, et al. Guidelines for diagnosis and treatment of hepatocellular carcinoma with portal vein tumor thrombus in china (2021 edition)[J]. Liver Cancer, 2022, 11(4): 315-328.
|
| 7 |
Zhang L, Lin JB, Jia M, et al. Clinical and imaging features preoperative evaluation of histological grade and microvascular infiltration of hepatocellular carcinoma[J]. BMC Gastroenterol, 2022, 22(1): 369.
|
| 8 |
Sofia C, Cattafi A, Silipigni S, et al. Portal vein thrombosis in patients with chronic liver diseases: from conventional to quantitative imaging[J]. Eur J Radiol, 2021, 142: 109859.
|
| 9 |
Marti J, Giacca M, Alshebeeb K, et al. Analysis of preoperative portal vein embolization outcomes in patients with hepatocellular carcinoma: a single-center experience[J]. J Vasc Interv Radiol, 2018, 29(7): 920-926.
|
| 10 |
Carr BI, Guerra V, Donghia R, et al. Microscopic portal vein invasion in relation to tumor focality and dimension in patients with hepatocellular carcinoma[J]. J Gastrointest Surg, 2022, 26(2): 333-340.
|
| 11 |
Sakon M, Kobayashi S, Wada H, et al. "Logic-based medicine" is more feasible than "evidence-based medicine" in the local treatment for hepatocellular carcinoma[J]. Oncology, 2020, 98(5): 259-266.
|
| 12 |
Sun YF, Guo W, Xu Y, et al. Circulating tumor cells from different vascular sites exhibit spatial heterogeneity in epithelial and mesenchymal composition and distinct clinical significance in hepatocellular carcinoma[J]. Clin Cancer Res, 2018, 24(3): 547-559.
|
| 13 |
Sato N, Marubashi S. What is the optimal surgical treatment for hepatocellular carcinoma beyond the debate between anatomical versus non-anatomical resection[J]. Surg Today, 2022, 52(6): 871-880.
|
| 14 |
Okamura Y, Sugiura T, Ito T, et al. Anatomical resection is useful for the treatment of primary solitary hepatocellular carcinoma with predicted microscopic vessel invasion and/or intrahepatic metastasis[J]. Surg Today, 2021, 51(9): 1429-1439.
|
| 15 |
Kang KJ, Ahn KS. Anatomical resection of hepatocellular carcinoma: a critical review of the procedure and its benefits on survival[J]. World J Gastroenterol, 2017, 23(7): 1139-1146.
|
| 16 |
Kwon JH, Lee JW, Lee JW, et al. Effects of anatomical or non-anatomical resection of hepatocellular carcinoma on survival outcome[J]. J Clin Med, 2022, 11(5)：1369.
|
| 17 |
Molina-Romero FX, Palma-Zamora E, Morales-Soriano R, et al. Comparison of anatomical resection and non-anatomical resection in patients with hepatocellular carcinoma: propensity score matching method[J]. Cir Cir, 2019, 87(3): 328-336.
|
| 18 |
刘荣，赵国栋. 肝脏解剖：从尸体静态解剖学下的树干理论到临床潜能形态学下的流域学说[J/CD]. 中华腔镜外科杂志(电子版), 2018, 11(5): 257-260.
|
| 19 |
Franz M, Arend J, Wolff S, et al. Tumor visualization and fluorescence angiography with indocyanine green (ICG) in laparoscopic and robotic hepatobiliary surgery - valuation of early adopters from Germany[J]. Innov Surg Sci, 2021, 6(2): 59-66.
|
| 20 |
Chen H, Wang Y, Xie Z, et al. Application effect of ICG fluorescence real-time imaging technology in laparoscopic hepatectomy[J]. Front Oncol, 2022, 12: 819960.
|
| 21 |
Ogawa S, Kubo H, Murayama Y, et al. Rapid fluorescence imaging of human hepatocellular carcinoma using the beta-galactosidase-activatable fluorescence probe spider-betagal[J]. Sci Rep, 2021, 11(1): 17946.
|